ASCO GI 2021 | ASCO GI 2021: trial updates

Daniel Catenacci, MD, University of Chicago, Chicago, IL, provides an overview of some of the exciting data presented at this years American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium, including updated long-term results from the IMBrave150 (NCT03434379) and KEYNOTE-177 (NCT02563002) studies. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).